An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Medical Case Reports | Volume-5 | Issue-02
Use of topical dorzolamide in a patient with X-linked juvenile retinoschisis
Shinji Makino
Published: Feb. 28, 2017 | 274 184
DOI: 10.36347/sjmcr.2017.v05i02.008
Pages: 91-93
Downloads
Abstract
We present a patient with X-linked juvenile retinoschisis before and after a topical use of dorzolamide. Ophthalmologic examinations showed a best corrected visual acuity (BCVA) of 0.3 in the right eye and 0.5 in the left eye. Fundoscopy demonstrated the typical stellate maculopathy of radiating cystoid spaces. Moreover, optical coherence tomography (OCT) results revealed a cleavage of the retina with thin-walled, vertical palisades separated by low reflective cystoid spaces. The patient was instructed to apply 2% dorzolamide three times daily in each eye. During a 3-month treatment period, OCT revealed a marked improvement in the foveal cystic lesions in the right eye, but not in the left eye. Moreover, BCVA was 0.6 in the right eye and 0.5 in the left eye after the 3-month treatment with dorzolamide. Our findings suggest that topical dorzolamide have some effect on improving foveal cystic lesions but it does not improve BCVA significantly.